Pharmacologic mechanisms of crystal meth

Kish, Stephen J.
June 2008
CMAJ: Canadian Medical Association Journal;6/17/2008, Vol. 178 Issue 13, p1679
Academic Journal
Crystal meth is a form of the stimulant drug methamphetamine that, when smoked, can rapidly achieve high concentrations in the brain. Methamphetamine causes the release of the neurotransmitters dopamine, norepinephrine and serotonin and activates the cardiovascular and central nervous systems. The levels of dopamine are low in the brain of some drug users, but whether this represents neuronal loss is uncertain. The areas of the brain involved in methamphetamine addiction are unknown but probably include the dopamine-rich striatum and regions that interact with the striatum. There is no medication approved for the treatment of relapses of methamphetamine addiction; however, potential therapeutic agents targeted to dopamine and nondopamine (e.g., opioid) systems are in clinical testing.


Related Articles

  • Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics. Sato, T.; Kitayama, S.; Mitsuhata, C.; Ikeda, T.; Morita, K.; Dohi, T. // Naunyn-Schmiedeberg's Archives of Pharmacology;Feb2000, Vol. 361 Issue 2, p214 

    Synthetic local anesthetics (LAs) have been found to have cocaine-like characteristics with some psychotomimetic action, possibly through monoaminergic neurotransmission. To gain insight into the relation between LA action and monoamine transporters, we investigated the effect of synthetic LAs...

  • Neuropeptides and monoaminergic neurotransmitters: their relation to pain. Sweet, William H. // Journal of the Royal Society of Medicine;Jul1980, Vol. 73 Issue 7, p482 

    The article focuses on the study conducted in the U.S. regarding the impact of pain on neuropeptides and monoamigernic neurotransmitters. The authors discuss the importance of discovering oligopeptides in the central nervous system and its significance to the identification of the amino acid...

  • Right place at the right time. Sanes, Dan H. // Nature Neuroscience;Mar2002, Vol. 5 Issue 3, p187 

    A puzzle of systems neuroscience, how the CNS encodes time intersects with a question that fascinates developmental biologists, the elimination of synaptic connections.

  • PII-36*. Mendelson, J.; Jones, R. T.; Fernandez, E.; Karan, L.; Chiang, N. // Clinical Pharmacology & Therapeutics;Feb2006, Vol. 79 Issue 2, pP45 

    Background: Reserpine is being evaluated as a pharmacotherapy for methamphetamine (MA) addiction. Sustained reserpine dosing depletes CNS monoamines. However, the first dose of reserpine can increase neurotransmitter levels. If reserpine and MA both increase CNS monoamine levels a larger PD...

  • INTERACCIÓN DE LA SEROTONINA Y LA CLOPAMINA EVIDENCIA EXPERIMENTAL E IMPORTANCIA TERAPÉUTICA. González-Burgos, Ignacio; Feria-Velasco, Alfredo // Archivos de Neurociencias;ene-mar2009, Vol. 14 Issue 1, p40 

    Both serotonin and dopamine neurotransmitters play a key role in modulating synaptic transmission in the central nervous system. Such serotonin-and-dopamine-mediated modulatory activity has been shown to influence a wide variety of cerebral functions both of instrumental and cognitive nature....

  • COMPANY SPOTLIGHT-- Eli Lilly and Company.  // PharmaWatch: CNS;August 2004, Vol. 3 Issue 8, p19 

    The article presents information on Eli Lilly and Company's plans to disclose the results of all clinical trials for which it is a sponsor. The Indianapolis-based group will place all the data on a publicly available registry. The registry will include results of all phase I through phase IV...

  • Functional Significance of Co-Localization of GABA and Glu in Nerve Terminals: A Hypothesis. Somogyi, Jozsef // Current Topics in Medicinal Chemistry;May2006, Vol. 6 Issue 10, p969 

    Salient features of the co-transmission by GABA and Glu in neural signaling are summarized. Experimental data have been accumulating which demonstrate; i) GABA-immunoreactivity in and GABA-release from constitutively Gluergic hippocampal mossy fibre terminals, ii) plasticity of the GABAergic...

  • Serotonin. Ratajczak, Helen V.; Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p583 

    A definition of the term "serotonin" is presented. It is categorized as a hormone and has been found to be the most diverse physiological substance in the body. Its functions as a neurotransmitter in the central nervous system include the regulation of functions, such as sleep, mood and...

  • Expression of serotonin (5-HT) during CNS development of the cephalopod mollusk, Idiosepius notoides. Wollesen, Tim; Degnan, Bernard M.; Wanninger, Andreas // Cell & Tissue Research;Nov2010, Vol. 342 Issue 2, p161 

    Cephalopods are unique among mollusks in exhibiting an elaborate central nervous system (CNS) and remarkable cognitive abilities. Despite a profound knowledge of the neuroanatomy and neurotransmitter distribution in their adult CNS, little is known about the expression of neurotransmitters...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics